P. Vermeire (Antwerp, Belgium), D. Sparrow (Boston, USA)
Prospective study of antioxidant vitamins and risk of adult-onset asthma and chronic obstructive pulmonary disease in women
C. A. Camargo Jr, R. G. Barr, W. C. Willett, C. C. Wentowski, F. E. Speizer (Boston, United States Of America)
|  |
Peak expiratory flow and 4-year occurrence of carotid atherosclerotic plaques
M. Zureik, F. Kauffmann, P. J. Touboul, D. Courbon, P. Ducimetiere (Villejuif, Paris, France)
| |
Hierarchical linear models for longitudinal change in COPD - is there an effect of differential dropout between treatment groups on estimated decline rates?
S. Spencer, P. W. Jones (London, United Kingdom)
| |
Age cohort mortality differences for respiratory and cardiovascular causes of death
D. L. Sherrill, M. D. Lebowitz (Tucson, United States Of America)
| |
Incidence and risk factors of acute exacerbations of COPD in Italy
S. Mannino, M. Sturkenboom, C. Logroscino, A. Dolcetti, S. Lo Cicero, G. Losito, O. Penza, F. De Benedetto, C. F. Donner, C. M. Sanguinetti, F. Mainini, S. Nardini (Milano, Italy)
| |
Rapid decline in FEV1 in a general population sample - report from the obstructive lung disease in Northern Sweden studies (OLIN)
B. Lundbäck, A. Lindberg, E. Jönsson, M. Lindström, E. Rönmark, K. Larsson, T. Sandström (Stockholm, Luleå, Umeå, Sweden)
| |
Is health related quality of life an independent predictor of mortality in COPD patients?
A. Domingo-Salvany, R. Lamarca, J. Garcia-Aymerich, M. Ferrer, J. Alonso, G. Vilagut, M. A. Félez, A. Khalaf, E. Monsó, R. Marrades, J. Serra-Batlle, J. M. Antó (Barcelona, Castellon, Badalona, Vic, Spain)
| |
21 year follow-up of pulmonary function and disease in α 1-antitrypsin MZ heterozygotes
M. Dahl, A. Tybjaerg-Hansen, P. Lange, J. Vestbo, B. G. Nordestgaard (Herlev, Copenhagen, Hvidovre, Denmark)
| |